Emerging Therapies, September 2023 eBook

Plasmid DNA (pDNA) is a critical raw material for the manufacture of cell and gene therapies. As this market continues to grow, so too does the demand for high-quality pDNA.

Scientists are leveraging ddPCR technology to get an accurate read on viral titer and vector copy number.

As more novel therapy approvals trend towards biologics, it is important to take stock of what treatments are shaping the future of the market.

Cold chain stakeholders continue to innovate with new technology development, the use of advanced modeling and analytics capabilities, and the pursuit of strategic partnerships.

Despite its success, clinical and logistical roadblocks to mRNA cancer vaccine development remain.